ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -12 مورد

Diagnostic tests for cytomegalovirus*

Diagnostic tests for cytomegalovirus*
  Serology Quantitative PCR AntigenemiaΔ Culture Histopathology Resistance testing
Immunocompetent
Acute or recent infection IgM or fourfold increase of IgG Plasma or whole blood        
Past infection IgG          
Critically ill   Plasma or whole blood; consider BAL§        
Immunocompromised
Assessing risk of CMV disease IgG          
Diagnosis of disease
  • Viral syndrome
  Plasma or whole blood PBMCs      
  • Pneumonitis
  Plasma or whole blood; consider BAL§ PBMCs BAL§ or lung tissue BAL§ or lung tissue  
  • Gastrointestinal disease
  Plasma or whole blood¥ PBMCs¥ Tissue Tissue  
  • Central nervous system disease
  CSF, plasma, whole blood        
  • Retinitis
  Vitreous or aqueous fluid        
Decisions regarding preemptive therapy   Plasma or whole blood PBMCs      
Monitoring response to therapy   Plasma or whole blood PBMCs      
Treatment failure   Plasma or whole blood PBMCs     Yes

BAL: bronchoalveolar lavage; CMV: cytomegalovirus; CSF: cerebrospinal fluid; IgG: immunoglobulin G; IgM: immunoglobulin M; PBMCs: peripheral blood polymorphonuclear leukocytes; PCR: polymerase chain reaction.

* Refer to the UpToDate topic reviews on diagnosis of CMV for detailed recommendations regarding the use of these assays. This table does not address diagnostic testing for CMV infection in neonates with congenital or perinatal CMV infection. For details on diagnostic testing in newborns, refer to the UpToDate table on laboratory tests for the detection of CMV in neonates with suspected congenital infection and topic reviews on congenital and perinatal CMV infection.

¶ Quantitative PCR assays offer several advantages over the antigenemia assay, including better assay standardization, increased stability of the specimen, smaller specimen volume, and the ability to test patients with leukopenia. For these reasons, quantitative PCR assays are more widely used than the antigenemia test, and we prefer them for the diagnosis and monitoring of immunocompromised patients with CMV infection and disease.

Δ The CMV antigenemia assay is insensitive when the patient has a low neutrophil count (<1000 cells/microL).

◊ This includes histopathology and immunohistochemical staining.

§ Identification of CMV on a BAL specimen may be difficult to interpret, as shedding of virus from respiratory secretions is common, even in the absence of disease. Identification of CMV on lung tissue is the gold standard for the diagnosis of CMV pneumonitis.

¥ Negative results are common with gastrointestinal disease.

Graphic 101937 Version 3.0